ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 75 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 6.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $131,000 | -52.4% | 210,981 | -0.5% | 0.00% | – |
| Q3 2018 | $275,000 | -2.1% | 211,976 | +1.8% | 0.00% | – |
| Q2 2018 | $281,000 | -85.2% | 208,282 | -84.1% | 0.00% | – |
| Q1 2018 | $1,899,000 | -35.2% | 1,309,502 | +0.5% | 0.00% | – |
| Q4 2017 | $2,932,000 | -33.0% | 1,303,117 | +1.2% | 0.00% | – |
| Q3 2017 | $4,379,000 | -0.2% | 1,288,209 | +4.2% | 0.00% | – |
| Q2 2017 | $4,388,000 | +15.0% | 1,236,327 | +10.2% | 0.00% | – |
| Q1 2017 | $3,816,000 | +63500.0% | 1,122,293 | +89112.5% | 0.00% | – |
| Q4 2016 | $6,000 | +20.0% | 1,258 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | +66.7% | 1,258 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | +200.0% | 1,258 | +433.1% | 0.00% | – |
| Q1 2016 | $1,000 | – | 236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,699,848 | $15,687,000 | 2.68% |
| Northeast Financial Consultants Inc | 732,265 | $3,105,000 | 1.31% |
| WEDBUSH SECURITIES INC | 15,000 | $64,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $628,000 | 0.01% |
| THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,752,000 | 0.01% |
| Virtu KCG Holdings LLC | 72,989 | $309,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,555 | $151,000 | 0.00% |
| WILLIAMS JONES & ASSOCIATES LLC | 15,100 | $64,000 | 0.00% |
| BlackRock Fund Advisors | 612,231 | $2,596,000 | 0.00% |
| Spot Trading L.L.C | 15,000 | $64,000 | 0.00% |